CN102614284B - Oral liquid for treating malignancy and preparing method - Google Patents
Oral liquid for treating malignancy and preparing method Download PDFInfo
- Publication number
- CN102614284B CN102614284B CN 201210106286 CN201210106286A CN102614284B CN 102614284 B CN102614284 B CN 102614284B CN 201210106286 CN201210106286 CN 201210106286 CN 201210106286 A CN201210106286 A CN 201210106286A CN 102614284 B CN102614284 B CN 102614284B
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- hours
- ethanol
- add
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 27
- 201000011510 cancer Diseases 0.000 title claims abstract description 13
- 206010028980 Neoplasm Diseases 0.000 title abstract description 7
- 238000000034 method Methods 0.000 title abstract description 3
- 230000036210 malignancy Effects 0.000 title abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 48
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 241000628997 Flos Species 0.000 claims description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 239000003814 drug Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 239000000284 extract Substances 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 238000002386 leaching Methods 0.000 claims description 3
- 238000004321 preservation Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000002512 chemotherapy Methods 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 8
- 238000001959 radiotherapy Methods 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 abstract description 2
- 235000011613 Pinus brutia Nutrition 0.000 abstract description 2
- 241000018646 Pinus brutia Species 0.000 abstract description 2
- 210000000582 semen Anatomy 0.000 abstract description 2
- 240000000774 Cunila origanoides Species 0.000 abstract 1
- 235000018274 Cunila origanoides Nutrition 0.000 abstract 1
- 235000014866 Dictamnus albus Nutrition 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000019082 Osmanthus Nutrition 0.000 abstract 1
- 241000333181 Osmanthus Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 235000015398 thunder god vine Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 235000006463 Brassica alba Nutrition 0.000 description 1
- 206010064571 Gene mutation Diseases 0.000 description 1
- 241000124079 Mylabris Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000220262 Sinapis alba Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000009969 fructus bruceae Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000011581 secondary neoplasm Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 231100000004 severe toxicity Toxicity 0.000 description 1
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses an oral liquid for treating malignancy and a preparing method. The oral liquid is mainly used for improving human immunity and chooses pine needles, dandelion, sweet-scented osmanthus, folium mori, Ligusticum wallichii, the root bark of shaggy-fruited dittany, thunder god vine, orange peel, semen brassicae, green plum blossom and Chinese date for preparing the oral liquid. According to clinical observation in hospital, the oral liquid has the function of enhancing immunity, invigorating blood circulation and reducing phlegm and resolving masses, has excellent curative effect on medium and later period lung cancer and liver cancer and especially can remarkably improve chemotherapy and radiotherapy effects. The oral liquid is free of toxic and side effects, convenient to take and worth of clinical promotion.
Description
Technical field
The present invention relates to a kind of Chinese medicine oral liquid, relate in particular to a kind of oral liquid and preparation method for the treatment of malignant tumor.
Background technology
Along with modern society's high speed development, various paathogenic factors are more and more, as environmental pollution, unhygienic diet, pressure is excessive, and living not, rhythm and pace of moving things etc. all will cause tumor patient more and more diversified, and present a rapidly rising trend, at present the expert is consistent thinks, operation, radiation and chemotherapy are considered to treat " three magic weapons " of tumor, solved to a certain extent really cancer at the moment with some problem of part.But its side effect is very big, and wherein the overwhelming majority can cause leukopenia.Operation and radiotherapy can only solve local problem; Chemotherapy also can not be killed all cancerous cell because being subjected to the each side condition restriction, and the injury of human heaviness is easy to form the secondary tumor.Traditional method for the treatment of mostly is " treating the poisonous disease with poisonous drugs ", though can kill and wound some cancerous cell, has also damaged a large amount of human normal tissue cells, and what is called loses more than gain.And traditional Chinese medicine cancer also mostly all is with some the medicine of severe toxicity such as Mylabris, arsenicum, Natrii Sulfas, Fructus Bruceae, Semen Strychni etc. to be arranged, if these Chinese medicines are long-term or large dose oral administration also can cause certain infringement to some internal organs of human body, and might produce accumulate poisoning.Therefore seeking new Therapeutic Method according to traditional Chinese medical science strengthening vital QI to eliminate pathogenic factors theory very presses for.
Summary of the invention
The purpose of this invention is to provide a kind for the treatment of to improve body immunity, have enhance immunity, promoting blood circulation and detoxication, the Chinese medicine oral liquid of dissipating phlegm and resolving masses.
The objective of the invention is to be achieved through the following technical solutions, the oral liquid of this treatment malignant tumor is made by following parts by weight of Chinese traditional medicine: Folium Pini 25-35 part, Herba Taraxaci 10-20 part, Flos Osmanthi Fragrantis 15-20 part, Folium Mori 20-30 part, Rhizoma Chuanxiong 15-25 part, Cortex Dictamni 15-20 part, Radix Tripterygii Wilfordii 10-15 part, Pericarpium Citri tangerinae 15-25 part, Semen Sinapis Albae 8-12 part, FLOS MUME 8-12 part, Fructus Jujubae 15-25 part.
Preferably, the oral liquid of this treatment malignant tumor is made by following parts by weight of Chinese traditional medicine: 30 parts in Folium Pini, 15 parts of Herba Taraxacis, 17 parts of Flos Osmanthi Fragrantis, 25 parts on Folium Mori, 20 parts of Rhizoma Chuanxiongs, 17 parts of Cortex Dictamni, 20 parts of 12 parts of Pericarpium Citri tangerinaes of Radix Tripterygii Wilfordii, 10 parts of Semen Sinapis Albaes, 10 parts of FLOS MUME, 20 parts in Fructus Jujubae.
The preparation method of this oral liquid is: take by weighing above Chinese crude drug Folium Pini 300g in proportion, Rhizoma Chuanxiong 200g, Cortex Dictamni 170g, Radix Tripterygii Wilfordii 120g, Pericarpium Citri tangerinae 200g, Semen Sinapis Albae 100g, FLOS MUME 100g, Fructus Jujubae 200g, decoct with water three times, 1.5 hours for the first time, second, three times each 1 hour, collecting decoction filtered, filtrate concentrates and add the 2mol/L hydrochloric acid solution in the time of 70 ℃ regulates pH value to 1.0～1.5 in right amount, be incubated 1 hour, left standstill 10 hours, filter, precipitation adds 6～8 times of water gagings, regulate pH value to 7.0 with 40% sodium hydroxide solution, add equivalent ethanol again, stir and make dissolving, filter, filtrate is regulated pH value to 2.0 with the 2mol/L hydrochloric acid solution, and 70 ℃ are incubated 30 minutes, left standstill 10 hours, filter, precipitation is washed till pH value 7.0 with ethanol, and it is standby to wave most ethanol, obtains extract A; Herba Taraxaci 150g, Flos Osmanthi Fragrantis 170g, after Folium Mori 250g adds water temperature and soaks half an hour, decoct secondary, each 1 hour, collecting decoction filters, and it is 1.20～1.25 (60～70 ℃ of surveys) that filtrate is concentrated into sweet relatively degree, slowly add ethanol when being chilled to 40 ℃, make to contain alcohol amount and reach 75%, fully stir, left standstill 12 hours, it is an amount of that leaching supernatant, residue add 75% ethanol, stir evenly, left standstill 10 hours, filter, merge ethanol liquid, reclaim ethanol to there not being the alcohol flavor, add extract A, and it is an amount of to add water, regulates pH value to 7.0 with 40% sodium hydroxide solution, stirs evenly, cold preservation (4～8 ℃) 72 hours filters, and filtrate adds sucrose 300g, stirring makes dissolving, adds essence more in right amount and regulates pH value to 7.0, adds water and makes 1100ml, stir evenly, left standstill 10 hours, and filtered fill, sterilization, namely.
In the side: Folium Pini expelling wind and activating blood circulation, the detoxifcation of calming the nerves; The Folium Mori dispelling wind and heat pathogens, clearing away lung-heat and moistening for dryness, suppressing liver-YANG; The Herba Taraxaci heat-clearing and toxic substances removing, dispersing swelling and dissipating binds; The broken knot of Flos Osmanthi Fragrantis cold expelling, preventing phlegm from forming and stopping coughing; The Rhizoma Chuanxiong blood-activating and qi-promoting, wind-expelling pain-stopping; During Pericarpium Citri tangerinae is regulated the flow of vital energy and is transferred, drying dampness to eliminate phlegm; The Radix Tripterygii Wilfordii detoxifcation of dispeling the wind; Semen Sinapis Albae warming the lung eliminating phlegm promoting the circulation of QI, the resolving mass and removing the obstruction of the collateral pain relieving; FLOS MUME soothing liver-QI stomach function regulating reduces phlegm; The Fructus Jujubae invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.Be rich in antioxidation, defying age material pine needle flavone in the Folium Pini, this material has unique water solublity, the contained unsaturated fatty acid of energy and Folium Pini sees through blood vessel wall and enters blood, fat and cholesterol in the dissolving blood vessel, by increasing bile secretion, reduce the accumulation of cholesterol, thereby prevention of arterial hardens, improves erythrocytic oxygen carrying capacity, blood circulation promoting.The selenium element that contains in the Folium Pini is consistent anticancer element of generally acknowledging in the world, is described as " anticancer king ".Folium Mori can prevent cancerous cell to generate, and improve body immunity, and the major function composition is DNJ, flavonoid, Sang Su, γ-An Jidingsuan and vitamin, can suppress chromosome mutation and gene mutation.
Clinical data
To coming the tumor patient of my institute's treatment, we have done clinical observation, to 185 routine pulmonary carcinoma, in the summary of hepatocarcinoma patient with oral liquid treatment of the present invention, III phase and IV phase patient account for 90% in the 132 routine pulmonary carcinoma, are 29.5% with the effective percentage of oral liquid treatment of the present invention.Under the same terms, the efficient that chemotherapy group (VCR+CTX+5F U) has is 13.4%, and it is 46.2% that chemotherapy adds the effective percentage of taking oral liquid of the present invention, raising evident in efficacy; The radiotherapy effective percentage is 30.7%, and radiotherapy adds the effective percentage of taking oral liquid treatment of the present invention and reaches 58.3%.In 53 routine hepatocarcinoma, in, patients with terminal accounts for 96.2%, is 70.3% with the effective percentage of oral liquid treatment of the present invention, the effective percentage of chemotherapy group (MMC+5FU) is 12.5%, it is 56.2% that chemotherapy adds oral liquid effective percentage of the present invention, than simple chemotherapy significant effective.112 routine late malignant tumours are treated by my institute, wherein 72 examples routinely chemotherapy, radiotherapy add oral liquid of the present invention, treatment finishes back 1 month, stable curative effect does not have new focus and occurs.Illustrate that this medicine cooperates with chemotherapy, radiotherapy, respond well, played the obvious synergistic antitumaous effect; Though in addition 40 routine late malignant tumour patients have lost the chance of operation and chemotherapy, radiotherapy, add Comprehensive Treatment with oral liquid of the present invention, produce effects adds totally 21 examples effectively, total effective rate 52.5% as a result.Simultaneously patient's subjective symptoms, abdominal distention tight as cough, gas, pain etc. all obviously alleviate, and appetite takes a turn for the better, and immunologic function strengthens.
Simultaneously, in clinical observation, do not find significant side effects.
The specific embodiment
Embodiment: take by weighing above Chinese crude drug Folium Pini 300g in proportion, Rhizoma Chuanxiong 200g, Cortex Dictamni 170g, Radix Tripterygii Wilfordii 120g, Pericarpium Citri tangerinae 200g, Semen Sinapis Albae 100g, FLOS MUME 100g, Fructus Jujubae 200g, decoct with water three times, 1.5 hours for the first time, second, three times each 1 hour, collecting decoction filtered, filtrate concentrates and add the 2mol/L hydrochloric acid solution in the time of 70 ℃ regulates pH value to 1.0～1.5 in right amount, be incubated 1 hour, left standstill 10 hours, filter, precipitation adds 6～8 times of water gagings, regulate pH value to 7.0 with 40% sodium hydroxide solution, add equivalent ethanol again, stir and make dissolving, filter, filtrate is regulated pH value to 2.0 with the 2mol/L hydrochloric acid solution, and 70 ℃ are incubated 30 minutes, left standstill 10 hours, filter, precipitation is washed till pH value 7.0 with ethanol, and it is standby to wave most ethanol, obtains extract A; Herba Taraxaci 150g, Flos Osmanthi Fragrantis 170g, after Folium Mori 250g adds water temperature and soaks half an hour, decoct secondary, each 1 hour, collecting decoction filters, and it is 1.20～1.25 (60～70 ℃ of surveys) that filtrate is concentrated into sweet relatively degree, slowly add ethanol when being chilled to 40 ℃, make to contain alcohol amount and reach 75%, fully stir, left standstill 12 hours, it is an amount of that leaching supernatant, residue add 75% ethanol, stir evenly, left standstill 10 hours, filter, merge ethanol liquid, reclaim ethanol to there not being the alcohol flavor, add extract A, and it is an amount of to add water, regulates pH value to 7.0 with 40% sodium hydroxide solution, stirs evenly, cold preservation (4～8 ℃) 72 hours filters, and filtrate adds sucrose 300g, stirring makes dissolving, adds essence more in right amount and regulates pH value to 7.0, adds water and makes 1100ml, stir evenly, left standstill 10 hours, and filtered fill, sterilization, namely.
Claims (2)
1. an oral liquid for the treatment of malignant tumor is characterized in that the oral liquid of this treatment malignant tumor is made by following parts by weight of Chinese traditional medicine: Folium Pini 25-35 part, Herba Taraxaci 10-20 part, Flos Osmanthi Fragrantis 15-20 part, Folium Mori 20-30 part, Rhizoma Chuanxiong 15-25 part, Cortex Dictamni 15-20 part, Radix Tripterygii Wilfordii 10-15 part, Pericarpium Citri tangerinae 15-25 part, Semen Sinapis Albae 8-12 part, FLOS MUME 8-12 part, Fructus Jujubae 15-25 part.
2. preparation method for the treatment of the oral liquid of malignant tumor, it is characterized in that: take by weighing Chinese crude drug Folium Pini 300g in proportion, Rhizoma Chuanxiong 200g, Cortex Dictamni 170g, Radix Tripterygii Wilfordii 120g, Pericarpium Citri tangerinae 200g, Semen Sinapis Albae 100g, FLOS MUME 100g, Fructus Jujubae 200g, decoct with water three times, 1.5 hours for the first time, second, three times each 1 hour, collecting decoction, filter, filtrate concentrates and add the 2mol/L hydrochloric acid solution in the time of 70 ℃ regulates pH value to 1.0～1.5 in right amount, is incubated 1 hour, left standstill 10 hours, filter, precipitation adds 6～8 times of water gagings, regulates pH value to 7.0 with 40% sodium hydroxide solution, add equivalent ethanol again, stirring makes dissolving, filters, and filtrate is regulated pH value to 2.0 with the 2mol/L hydrochloric acid solution, 70 ℃ are incubated 30 minutes, left standstill 10 hours, and filtered, precipitation is washed till pH value 7.0 with ethanol, it is standby to wave most ethanol, obtains extract A; Herba Taraxaci 150g, Flos Osmanthi Fragrantis 170g, after Folium Mori 250g adds water temperature and soaks half an hour, decoct secondary, each 1 hour, collecting decoction filters, and it is 1.20～1.25 that filtrate is concentrated into 60～70 ℃ of relative densities of measuring down, slowly add ethanol when being chilled to 40 ℃, make to contain alcohol amount and reach 75%, fully stir, left standstill 12 hours, it is an amount of that leaching supernatant, residue add 75% ethanol, stir evenly, left standstill 10 hours, filter, merge ethanol liquid, reclaim ethanol to there not being the alcohol flavor, add extract A, and it is an amount of to add water, regulates pH value to 7.0 with 40% sodium hydroxide solution, stirs evenly, 4～8 ℃ of following cold preservations 72 hours, filter, filtrate adds sucrose 300g, stirring makes dissolving, adds essence more in right amount and regulates pH value to 7.0, adds water and makes 1100ml, stir evenly, left standstill 10 hours, and filtered fill, sterilization, namely.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210106286 CN102614284B (en) | 2012-04-02 | 2012-04-02 | Oral liquid for treating malignancy and preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210106286 CN102614284B (en) | 2012-04-02 | 2012-04-02 | Oral liquid for treating malignancy and preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102614284A CN102614284A (en) | 2012-08-01 |
| CN102614284B true CN102614284B (en) | 2013-08-14 |
Family
ID=46554732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210106286 Active CN102614284B (en) | 2012-04-02 | 2012-04-02 | Oral liquid for treating malignancy and preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102614284B (en) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100583051B1 (en) * | 2003-12-31 | 2006-05-24 | 한국생명공학연구원 | Extracts of cinnamon and zizyphus zuzuba for the prevention and treatment of cancers |
| CN1311862C (en) * | 2004-09-03 | 2007-04-25 | 曾隆江 | Medicine for treating cancer |
| US20060269567A1 (en) * | 2005-05-16 | 2006-11-30 | Liu Yuen | Universal detoxifying composition |
| US20070248619A1 (en) * | 2006-04-21 | 2007-10-25 | Chang Cabezas Jorge P | New pharmaceutical composition from natural materials for regulating immunity, its preparation method and use |
| CN101073663A (en) * | 2007-02-16 | 2007-11-21 | 中山大学 | Chinese-medicinal composition for treating malignant tumor and its production |
| WO2009066712A1 (en) * | 2007-11-21 | 2009-05-28 | Kracie Pharma, Ltd. | Aromatase inhibitor |
| CN101670056B (en) * | 2008-09-10 | 2011-08-03 | 吴昆仑 | Medicament for treating malignant tumor |
| KR20100043882A (en) * | 2008-10-21 | 2010-04-29 | 김정환 | Extract of mulberry leaves having inhibition activity for helicobacter pylori, method for preparing the same and the healthfunctional food using thereof |
| CN101543616B (en) * | 2009-04-21 | 2012-07-04 | 闫树清 | Traditional Chinese medicine composition for preventing and treating tumor and its preparation method |
| CN102048805A (en) * | 2009-11-05 | 2011-05-11 | 天津太平洋制药有限公司 | Chinese medicinal preparation for treating malignant tumor and preparation method thereof |
-
2012
- 2012-04-02 CN CN 201210106286 patent/CN102614284B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102614284A (en) | 2012-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103719494B (en) | A kind of great burdock achene defaecation health care tea for moistening intestines and preparation method thereof | |
| CN102000216A (en) | Traditional Chinese medicine foot bath prescription for treating hypertension | |
| CN102210820A (en) | Chinese medicinal composition for treating leukemia | |
| CN104784617A (en) | Compound traditional Chinese medicine preparation for treating enterogastritis and preparation method thereof | |
| CN104605372A (en) | Nutritional herbal cuisine based on cancer radiotherapy patient and preparation method thereof | |
| CN104367926A (en) | Traditional Chinese medicine preparation for treating predawn diarrhea and preparation method thereof | |
| CN102614284B (en) | Oral liquid for treating malignancy and preparing method | |
| CN107260994A (en) | A kind of Chinese medicine dietotherapy composition of anti-curing oncoma and preparation method thereof | |
| CN103099885A (en) | Soft capsules having acne removing function and preparation method thereof | |
| CN105343866A (en) | Traditional Chinese medicine tablets for treating cold rheum coughs and preparation method | |
| CN103690902B (en) | For preventing the Chinese medicine preparation of nasopharyngeal carcinoma radiation side reaction | |
| CN102949466A (en) | Foot bathing liquid for yang promotion and solid doff | |
| CN103211949B (en) | Traditional Chinese medicine composition for treating gastric diseases of human body as well as preparation method and application thereof | |
| CN107432924A (en) | A kind of traditional Chinese herbal decoction for treating nettle rash | |
| CN102755453B (en) | A kind of fumigation-washing medicine treating chronic eczema of scrotum | |
| CN101461854B (en) | Colitis treating Chinese medicine preparation | |
| CN101347513A (en) | Medicine for treating cancer | |
| CN106177438B (en) | A kind of Chinese medicine composition for treating kidney and preparation method thereof | |
| CN104800693B (en) | A kind of Chinese medicine composition for treating lung cancer | |
| CN103028104B (en) | Traditional Chinese medicine composition for treating abdominal pain | |
| CN103157032B (en) | Postoperative medicine for chondroblastoma | |
| CN102233019A (en) | Biailing | |
| CN113876836A (en) | A topical Chinese medicinal composition for foot bath for children, and its preparation method | |
| CN109865003A (en) | The ointment and preparation method thereof for treating cutaneous pruritus caused by acne and eczema | |
| CN108057113A (en) | For treating neurasthenic Chinese herbal medicine formula |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUDONG TECHNOLOGY CENTER Effective date: 20150107 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 276000 LINYI, SHANDONG PROVINCE TO: 226400 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150107 Address after: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee after: Rudong science and Technology Center Address before: 276000 Linyi Tumour Hospital, Lanshan East Street, Lanshan District, Shandong, Linyi 6, China Patentee before: Zheng Meifang |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20200520 Address after: No. 10, Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Rudong industrial and commercial information consulting service center Address before: 226400 No. 66 Youyi West Road, dug Town, Rudong County, Jiangsu, Nantong Patentee before: Rudong science and Technology Center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20210826 Address after: 226400 No.8, wisdom Avenue, Donghu scenic area, Dayu Town, Rudong County, Nantong City, Jiangsu Province Patentee after: Nantong Donghu International Travel Agency Co.,Ltd. Address before: 226400 No.10 Fandi South Road, juegang Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Rudong industrial and commercial information consulting service center |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240814 Address after: No. 71 Honglian South Road, Xicheng District, Beijing 100000 Patentee after: BEIJING HUAKE INTEGRATED TRADITIONAL AND WESTERN MEDICINE HOSPITAL Co.,Ltd. Country or region after: China Address before: 226400 No.8, wisdom Avenue, Donghu scenic area, Dayu Town, Rudong County, Nantong City, Jiangsu Province Patentee before: Nantong Donghu International Travel Agency Co.,Ltd. Country or region before: China |
|
| TR01 | Transfer of patent right |